11月 2025
- 首頁
- Abbvie Contract Manufacturing
11月 2025Abbvie Contract Manufact...的市場佔有率分析
abbvie contract manufacturing has a track record of successful small molecule and biologics development,
giving your project a strategic head start.
Abbvie Contract Manufacturing(包含公司地區)
查看更多網站流量與參與度資訊- abbviecontractmfg.com
Abbvie Contract Manufacturing的熱門網域總造訪量
了解Abbvie Contract Manufacturing市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Abbvie Contract Manufacturing的熱門網域平均造訪時長
分析Abbvie Contract Manufacturing參與度指標。
過去 3 個月平均造訪時長
子公司細目
Abbvie Contract Manufacturing的熱門網域平均頁面瀏覽量
了解Abbvie Contract Manufacturing如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Abbvie Contract Manufacturing
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞AbbVie Inc. invested into assets: manufacturing plant in the amount of $223M on Jan 1st '24.Back in January, AbbVie said it broke ground on a $223 million expansion of its manufacturing plant in the country to help bolster global biologics capacity.
5月 16, 2024閱讀更多
新聞AbbVie Inc. partnered with Umoja Biopharma, Inc. on Jan 28th '24.Last month, AbbVie also inked two contracts with Seattle-based biotech Umoja Biopharma to develop several in-situ CAR-T therapies against various cancers.
2月 27, 2024閱讀更多
新聞AbbVie Inc. acquired Stemcentrx, Inc. for $5.8B on Jun 1st '16.In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash-and-stock deal worth $5.8 billion.
12月 31, 2023閱讀更多
查看所有Abbvie Contract Manufacturing信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。